Alvine Pharmaceuticals is dedicated to developing and commercializing therapeutics for the treatment of celiac sprue, a gluten-induced autoimmune disease for which no drug therapy is currently available. Celiac sprue is believed to affect as many as two million people in the U.S. alone, many of whom have suffered the symptoms of the disease but have not yet been diagnosed.
Total raised: $34M
Investors 2
| Date | Name | Website |
| - | InterWest ... | interwest.... |
| - | Sofinnova ... | sofinnova.... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 24.06.2008 | - | $26M | - | venturebea... |
| 06.09.2006 | - | $8M | Sofinnova ... | venturebea... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 24.01.2013 | Biopharma ... | Celiac disease is characterize... | - | - | medcitynew... |
| 26.05.2010 | Alvine Pha... | Alvine Pharmaceuticals, Inc., ... | USA ventu... | - | finsmes.co... |
| 15.09.2009 | USA, Alvin... | Alvine Pharmaceuticals, a biop... | Start Up ... | - | finsmes.co... |
| 24.06.2008 | Alvine Pha... | San Carlos, Calif. company Alv... | - | - | venturebea... |
| 06.09.2006 | Alvine Pha... | Alvine Pharmaceuticals Inc., a... | - | - | venturebea... |
| - | Biopharma ... | A biopharmaceutical company th... | - | - | medcitynew... |